🇺🇸 FDA
Patent

US 11753623

Compositions for treating retinal diseases and methods for making and using them

granted A61KA61K35/30A61K9/0019

Quick answer

US patent 11753623 (Compositions for treating retinal diseases and methods for making and using them) held by The Regents of the University of California expires Mon Sep 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Sep 12 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K35/30, A61K9/0019, A61P, A61P27/02